Frontiers in Pharmacology (Nov 2022)

Editorial: Advances in non-alcoholic fatty liver disease therapeutics: Pathogenic mechanisms and targets

  • Ana Blas-García,
  • Ana Blas-García,
  • Ana Blas-García,
  • Francisco Javier Cubero,
  • Francisco Javier Cubero,
  • Francisco Javier Cubero

DOI
https://doi.org/10.3389/fphar.2022.1072353
Journal volume & issue
Vol. 13

Abstract

Read online

No abstracts available.

Keywords